Low levels of E‐cadherin also correlate with shorter survival in SCLC patients (Chang et al, 2012), but few molecular studies have specifically investigated the role of E‐cadherin in the migration and metastasis of SCLC cells. This evidence concerns the gene CDH1 and small cell lung carcinoma.